BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 11, 2006
View Archived Issues
GSK Acquiring Young Antibody Firm Domantis For $454M Cash
In the latest example of big pharma turning to biotech to beef up its research and development pipelines, GlaxoSmithKline plc agreed to acquire Domantis Ltd. for £230 million (US$454 million) in cash. (BioWorld Today)
Read More
Arena Pharmaceuticals Gets $159M For Stoked Pipeline
Read More
Double Trouble: Malaria, HIV Infection Feed Each Other
Read More
Theravance Submits NDA For Antibiotic Telavancin
Read More
Senate Finally OKs Von Eschenbach As FDA Head
Read More
Other News To Note
Read More
Clinic Roundup
Read More